{"id":370,"date":"2019-10-03T12:00:23","date_gmt":"2019-10-03T12:00:23","guid":{"rendered":"http:\/\/skin-cancer2020.www.bioevents.net\/?page_id=370"},"modified":"2022-03-21T09:23:27","modified_gmt":"2022-03-21T09:23:27","slug":"dear-colleague","status":"publish","type":"page","link":"https:\/\/med-cannabis2022.com\/dear-colleague\/","title":{"rendered":"Dear Colleague"},"content":{"rendered":"
It is our pleasure to invite you to participate in\u00a0The 3rd<\/sup> International Annual Congress on Controversies on Cannabis-Based Medicines (Med-Cannabis2022)<\/strong>\u00a0which will take place\u00a002-03 November 2022<\/strong>\u00a0in\u00a0Copenhagen, Denmark.\u00a0<\/strong><\/span><\/p>\n Med-Cannabis2022<\/strong>\u00a0will address the many controversies surrounding cannabis-based medicines. Strong public and patient demand has led to the decision to allow cannabis products for medical use in most European countries. There is a lot of basic-science and clinical research on the potential use of cannabis products for chronic pain and cancer management as well as controversies on the potential harms.<\/span><\/p>\n This Congress will bring together researchers, clinicians, trialists, methodologists, industry professionals, the European Monitoring Centre for Drugs and Drug Addiction, and national cannabis agencies to update the current state of knowledge and of controversies and to outline some visions of the potential of cannabis based medicines.<\/span><\/p>\n The program will include a wealth of knowledge from our world renowned panel of experts. We look forward to seeing you at\u00a0Med-Cannabis2022 <\/strong>in the charming city of Copenhagen.<\/span><\/p>\n Sincerely,<\/span><\/p>\n Dr. Silviu Brill<\/span><\/strong><\/p>\n Congress Chair<\/span><\/em><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n <\/p>\n <\/p>\n <\/p>\n It is our pleasure to invite you to participate in\u00a0The 3rd International Annual Congress on Controversies on Cannabis-Based Medicines (Med-Cannabis2022)\u00a0which will take place\u00a002-03 November 2022\u00a0in\u00a0Copenhagen, Denmark.\u00a0 Med-Cannabis2022\u00a0will address the many controversies surrounding cannabis-based medicines. Strong public and patient demand has led to the decision to allow cannabis products for medical use in most European countries. […]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-370","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\n\n\n
\n <\/td>\n<\/tr>\n \n \n <\/h3>\n","protected":false},"excerpt":{"rendered":"